Cargando…

Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial

BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Chen, Xiaoyun, Cheng, Yanqi, Chen, Qilong, Tan, Hongsheng, Son, Dongwook, Chang, Dongpill, Bian, Zhaoxiang, Fang, Hong, Xu, Hongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823766/
https://www.ncbi.nlm.nih.gov/pubmed/31695571
http://dx.doi.org/10.1016/j.jgr.2019.05.006
_version_ 1783464592768237568
author Zhang, Li
Chen, Xiaoyun
Cheng, Yanqi
Chen, Qilong
Tan, Hongsheng
Son, Dongwook
Chang, Dongpill
Bian, Zhaoxiang
Fang, Hong
Xu, Hongxi
author_facet Zhang, Li
Chen, Xiaoyun
Cheng, Yanqi
Chen, Qilong
Tan, Hongsheng
Son, Dongwook
Chang, Dongpill
Bian, Zhaoxiang
Fang, Hong
Xu, Hongxi
author_sort Zhang, Li
collection PubMed
description BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥性 in Chinese). The aim of this study was to assess the safety and efficacy of a 4-week treatment with KRG in participants with deficiency syndrome. METHODS: This was a 4-week, randomized, double-blind, placebo-controlled clinical trial. A total of 180 Chinese participants were randomly allocated to three groups: placebo control group, participants were given a placebo, 3.6 g/d; KRG 1.8 g and 3.6 g groups. The primary outcomes were the changes in fireness and safety evaluation (adverse events, laboratory tests, and electrocardiogram). The secondary outcomes were the efficacy of KRG on fatigue, which include the following: traditional Chinese medicine (TCM) symptom scale and fatigue self-assessment scale. RESULTS: Of the 180 patients, 174 completed the full study. After 4 weeks of KRG treatment, the Fire-heat symptoms score including Excess fire-heat score and Deficient fire-heat score showed no significant change as compared with placebo treatment, and no clinically significant changes in any safety parameter were observed. Based on the TCM syndrome score and fatigue self-assessment score, TCM symptoms and fatigue were greatly improved after treatment with KRG, which showed a dose- and time-dependent effect. The total effective rate was also significantly increased in the KRG groups. CONCLUSION: Our study revealed that KRG has a potent antifatigue effect without significant adverse effects in people with deficiency syndrome. Although a larger sample size and longer treatment may be required for a more definite conclusion, this clinical trial is the first to disprove the common conception of “fireness” related to KRG.
format Online
Article
Text
id pubmed-6823766
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68237662019-11-06 Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial Zhang, Li Chen, Xiaoyun Cheng, Yanqi Chen, Qilong Tan, Hongsheng Son, Dongwook Chang, Dongpill Bian, Zhaoxiang Fang, Hong Xu, Hongxi J Ginseng Res Research Article BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause “fireness” (上火 in Chinese) because of its “dryness” (燥性 in Chinese). The aim of this study was to assess the safety and efficacy of a 4-week treatment with KRG in participants with deficiency syndrome. METHODS: This was a 4-week, randomized, double-blind, placebo-controlled clinical trial. A total of 180 Chinese participants were randomly allocated to three groups: placebo control group, participants were given a placebo, 3.6 g/d; KRG 1.8 g and 3.6 g groups. The primary outcomes were the changes in fireness and safety evaluation (adverse events, laboratory tests, and electrocardiogram). The secondary outcomes were the efficacy of KRG on fatigue, which include the following: traditional Chinese medicine (TCM) symptom scale and fatigue self-assessment scale. RESULTS: Of the 180 patients, 174 completed the full study. After 4 weeks of KRG treatment, the Fire-heat symptoms score including Excess fire-heat score and Deficient fire-heat score showed no significant change as compared with placebo treatment, and no clinically significant changes in any safety parameter were observed. Based on the TCM syndrome score and fatigue self-assessment score, TCM symptoms and fatigue were greatly improved after treatment with KRG, which showed a dose- and time-dependent effect. The total effective rate was also significantly increased in the KRG groups. CONCLUSION: Our study revealed that KRG has a potent antifatigue effect without significant adverse effects in people with deficiency syndrome. Although a larger sample size and longer treatment may be required for a more definite conclusion, this clinical trial is the first to disprove the common conception of “fireness” related to KRG. Elsevier 2019-10 2019-05-21 /pmc/articles/PMC6823766/ /pubmed/31695571 http://dx.doi.org/10.1016/j.jgr.2019.05.006 Text en © 2019 The Korean Society of Ginseng, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Zhang, Li
Chen, Xiaoyun
Cheng, Yanqi
Chen, Qilong
Tan, Hongsheng
Son, Dongwook
Chang, Dongpill
Bian, Zhaoxiang
Fang, Hong
Xu, Hongxi
Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title_full Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title_fullStr Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title_full_unstemmed Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title_short Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
title_sort safety and antifatigue effect of korean red ginseng: a randomized, double-blind, and placebo-controlled clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823766/
https://www.ncbi.nlm.nih.gov/pubmed/31695571
http://dx.doi.org/10.1016/j.jgr.2019.05.006
work_keys_str_mv AT zhangli safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT chenxiaoyun safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT chengyanqi safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT chenqilong safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT tanhongsheng safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT sondongwook safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT changdongpill safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT bianzhaoxiang safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT fanghong safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT xuhongxi safetyandantifatigueeffectofkoreanredginsengarandomizeddoubleblindandplacebocontrolledclinicaltrial